Gene Therapy on Cardiovascular Disease Market Size, Share, Growth, And Industry Analysis, By Type (Viral Gene Therapy and Non-Viral Gene Therapy), By Application (Heart Disease and Vascular Disease), and Regional Forecast From 2025 To 2033

Last Updated: 14 July 2025
SKU ID: 21064573
ask for customization Buy Now
ask for customization Request a FREE Sample PDF

Detailed TOC of Global Gene Therapy On Cardiovascular Disease Market Research Report 2033

  1. 1 Report Overview
    1. Study Scope
    2. Market Analysis by Type
      1. Global Gene Therapy On Cardiovascular Disease Market Size Growth Rate by Type: 2017 VS 2021 VS 2033
      2. Viral Gene Therapy
      3. Non-Viral Gene Therapy
    3. Market by Application
      1. Global Gene Therapy On Cardiovascular Disease Market Share by Application: 2017 VS 2021 VS 2033
      2. Heart Disease
      3. Vascular Disease
    4. Study Objectives
    5. Years Considered
  2. Global Growth Trends
    1. Global Gene Therapy On Cardiovascular Disease Market Perspective (2017-2033)
    2. Gene Therapy On Cardiovascular Disease Growth Trends by Region
      1. Gene Therapy On Cardiovascular Disease Market Size by Region: 2017 VS 2021 VS 2033
      2. Gene Therapy On Cardiovascular Disease Historic Market Size by Region (2017-2022)
      3. Gene Therapy On Cardiovascular Disease Forecasted Market Size by Region (2023-2033)
    3. Gene Therapy On Cardiovascular Disease Market Dynamics
      1. Gene Therapy On Cardiovascular Disease Industry Trends
      2. Gene Therapy On Cardiovascular Disease Market Drivers
      3. Gene Therapy On Cardiovascular Disease Market Challenges
      4. Gene Therapy On Cardiovascular Disease Market Restraints
  3. Competition Landscape by Key Players
    1. Global Top Gene Therapy On Cardiovascular Disease Players by Revenue
      1. Global Top Gene Therapy On Cardiovascular Disease Players by Revenue (2017-2022)
      2. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Players (2017-2022)
    2. Global Gene Therapy On Cardiovascular Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3. Players Covered: Ranking by Gene Therapy On Cardiovascular Disease Revenue
    4. Global Gene Therapy On Cardiovascular Disease Market Concentration Ratio
      1. Global Gene Therapy On Cardiovascular Disease Market Concentration Ratio (CR5 and HHI)
      2. Global Top 10 and Top 5 Companies by Gene Therapy On Cardiovascular Disease Revenue in 2021
    5. Gene Therapy On Cardiovascular Disease Key Players Head office and Area Served
    6. Key Players Gene Therapy On Cardiovascular Disease Product Solution and Service
    7. Date of Enter into Gene Therapy On Cardiovascular Disease Market
    8. Mergers & Acquisitions, Expansion Plans
  4. Gene Therapy On Cardiovascular Disease Breakdown Data by Type
    1. Global Gene Therapy On Cardiovascular Disease Historic Market Size by Type (2017-2022)
    2. Global Gene Therapy On Cardiovascular Disease Forecasted Market Size by Type (2023-2033)
  5. Gene Therapy On Cardiovascular Disease Breakdown Data by Application
    1. Global Gene Therapy On Cardiovascular Disease Historic Market Size by Application (2017-2022)
    2. Global Gene Therapy On Cardiovascular Disease Forecasted Market Size by Application (2023-2033)
  6. North America
    1. North America Gene Therapy On Cardiovascular Disease Market Size (2017-2033)
    2. North America Gene Therapy On Cardiovascular Disease Market Size by Country (2017-2022)
    3. North America Gene Therapy On Cardiovascular Disease Market Size by Country (2023-2033)
    4. United States
    5. Canada
  7. Europe
    1. Europe Gene Therapy On Cardiovascular Disease Market Size (2017-2033)
    2. Europe Gene Therapy On Cardiovascular Disease Market Size by Country (2017-2022)
    3. Europe Gene Therapy On Cardiovascular Disease Market Size by Country (2023-2033)
    4. Germany
    5. France
    6. U.K.
    7. Italy
    8. Russia
    9. Nordic Countries
  8. Asia-Pacific
    1. Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size (2017-2033)
    2. Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size by Country (2017-2022)
    3. Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size by Country (2023-2033)
    4. China
    5. Japan
    6. South Korea
    7. Southeast Asia
    8. India
    9. Australia
  9. Latin America
    1. Latin America Gene Therapy On Cardiovascular Disease Market Size (2017-2033)
    2. Latin America Gene Therapy On Cardiovascular Disease Market Size by Country (2017-2022)
    3. Latin America Gene Therapy On Cardiovascular Disease Market Size by Country (2023-2033)
    4. Mexico
    5. Brazil
  10. Middle East & Africa
    1. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size (2017-2033)
    2. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Country (2017-2022)
    3. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Country (2023-2033)
    4. Turkey
    5. Saudi Arabia
    6. UAE
  11. Key Players Profiles
    1. Biogen
      1. Biogen Company Detail
      2. Biogen Business Overview
      3. Biogen Gene Therapy On Cardiovascular Disease Introduction
      4. Biogen Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
      5. Biogen Recent Development
    2. Novartis
      1. Novartis Company Detail
      2. Novartis Business Overview
      3. Novartis Gene Therapy On Cardiovascular Disease Introduction
      4. Novartis Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
      5. Novartis Recent Development
    3. Gilead Sciences
      1. Gilead Sciences Company Detail
      2. Gilead Sciences Business Overview
      3. Gilead Sciences Gene Therapy On Cardiovascular Disease Introduction
      4. Gilead Sciences Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
      5. Gilead Sciences Recent Development
    4. Sarepta Therapeutics
      1. Sarepta Therapeutics Company Detail
      2. Sarepta Therapeutics Business Overview
      3. Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Introduction
      4. Sarepta Therapeutics Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
      5. Sarepta Therapeutics Recent Development
    5. Alnylam Pharmaceuticals
      1. Alnylam Pharmaceuticals Company Detail
      2. Alnylam Pharmaceuticals Business Overview
      3. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Introduction
      4. Alnylam Pharmaceuticals Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
      5. Alnylam Pharmaceuticals Recent Development
    6. Amgen
      1. Amgen Company Detail
      2. Amgen Business Overview
      3. Amgen Gene Therapy On Cardiovascular Disease Introduction
      4. Amgen Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
      5. Amgen Recent Development
    7. Spark Therapeutics
      1. Spark Therapeutics Company Detail
      2. Spark Therapeutics Business Overview
      3. Spark Therapeutics Gene Therapy On Cardiovascular Disease Introduction
      4. Spark Therapeutics Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
      5. Spark Therapeutics Recent Development
    8. Akcea Therapeutics
      1. Akcea Therapeutics Company Detail
      2. Akcea Therapeutics Business Overview
      3. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Introduction
      4. Akcea Therapeutics Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
      5. Akcea Therapeutics Recent Development
    9. bluebird bio
      1. bluebird bio Company Detail
      2. bluebird bio Business Overview
      3. bluebird bio Gene Therapy On Cardiovascular Disease Introduction
      4. bluebird bio Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
      5. bluebird bio Recent Development
    10. Sunway Biotech
      1. Sunway Biotech Company Detail
      2. Sunway Biotech Business Overview
      3. Sunway Biotech Gene Therapy On Cardiovascular Disease Introduction
      4. Sunway Biotech Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
      5. Sunway Biotech Recent Development
    11. SIBIONO
      1. SIBIONO Company Detail
      2. SIBIONO Business Overview
      3. SIBIONO Gene Therapy On Cardiovascular Disease Introduction
      4. SIBIONO Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
      5. SIBIONO Recent Development
    12. AnGes
      1. AnGes Company Detail
      2. AnGes Business Overview
      3. AnGes Gene Therapy On Cardiovascular Disease Introduction
      4. AnGes Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
      5. AnGes Recent Development
    13. Orchard Therapeutics
      1. Orchard Therapeutics Company Detail
      2. Orchard Therapeutics Business Overview
      3. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Introduction
      4. Orchard Therapeutics Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
      5. Orchard Therapeutics Recent Development
    14. Human Stem Cells Institute
      1. Human Stem Cells Institute Company Detail
      2. Human Stem Cells Institute Business Overview
      3. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Introduction
      4. Human Stem Cells Institute Revenue in Gene Therapy On Cardiovascular Disease Business (2017-2022)
      5. Human Stem Cells Institute Recent Development
  12. Analyst's Viewpoints/Conclusions
  13. Appendix
    1. Research Methodology
      1. Methodology/Research Approach
      2. Data Source
    2. Disclaimer
    3. Author Details